201 consecutive cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) procedures in a single Asian tertiary centre

References

• Sadeghi B, Arvieux C, Glehen O, et al. (2000). Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88:358–63.
   PubMed Web of Science ®Google Scholar
• Glehen O, Kwiatkowski F, Sugarbaker PH, et al. (2004). Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 22:3284–92.
   PubMed Web of Science ®Google Scholar
• Verwaal VJ, Bruin S, Boot H, et al. (2008). 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 15:2426–32.
   PubMed Web of Science ®Google Scholar
• Di Giorgio A, Naticchioni E, Biacchi D, et al. (2008). Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer. Cancer 113:315–25.
   PubMed Web of Science ®Google Scholar
• Yonemura Y, Kawamura T, Bandou E, et al. (2005). Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Br J Surg 92:370–75.
   PubMed Web of Science ®Google Scholar
• Teo M, Tan G, Lim C, et al. (2013). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Asian patients: 100 consecutive patients in a single institution. Ann Surg Oncol 20:2968–74.
   PubMed Web of Science ®Google Scholar
• Younan R, Kusamura S, Baratti D, et al. (2008). Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy. J Surg Oncol 98:253–57.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. (1995). Peritonectomy procedures. Ann Surg 221:29–42.
   PubMed Web of Science ®Google Scholar
• Witkamp AJ, de Bree E, Van Goethem R, Zoetmulder FA. (2001). Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy. Cancer Treat Rev 27:365–74.
   PubMed Web of Science ®Google Scholar
• Jacquet P, Sugarbaker PH. (1996). Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359–74.
   PubMedGoogle Scholar
• Teo M, Foo KF, Koo WH, et al. (2006). Lessons learnt from initial experience with peritonectomy and intra-peritoneal chemotherapy infusion. World J Surg 30:2132–36.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH, Ronnett BM, Archer A, et al. (1997). Pseudomyxoma peritonei syndrome. Adv Surg 30:233–80.
   Google Scholar
• Sugarbaker PH, Jablonsky KA. (1995). Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 221:124–32.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. (1999). Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 43:S15–S25.
   PubMed Web of Science ®Google Scholar
• Tan G, Ong WS, Chia CS, et al. (2016). Does early post-operative intraperitoneal chemotherapy (EPIC) for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) make a difference? Int J Hyperthermia 32:281–88.
   PubMed Web of Science ®Google Scholar
• Liu Y, Ishibashi H, Takeshita K, et al. (2016). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal dissemination from small bowel malignancy: results from a single specialized center. Ann Surg Oncol 23:1625–31.
   Google Scholar
• Liu Y, Ishibashi H, Hirano M, et al. (2015). Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei arising from urachus. Ann Surg Oncol 22:2799–805.
   PubMed Web of Science ®Google Scholar
• Huang CQ, Yang XJ, Yu Y, et al. (2014). Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for patients with peritoneal carcinomatosis from colorectal cancer: a phase II study from a Chinese center. PLoS One 9:e108509.
   PubMed Web of Science ®Google Scholar
• Mohamed F, Cecil TD, Moran BJ, Sugarbaker PH. (2011). A new standard of care for the management of peritoneal surface malignancy. Curr Oncol 18:e84–96.
   PubMed Web of Science ®Google Scholar
• Lord AC, Shihab O, Chandrakumaran K, et al. (2015). Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours. Eur J Surg Oncol 41:396–99.
   PubMed Web of Science ®Google Scholar
• Bae JH, Lee JM, Ryu KS, et al. (2007). Treatment of ovarian cancer with paclitaxel- or carboplatin-based intraperitoneal hyperthermic chemotherapy during secondary surgery. Gynecol Oncol 106:193–200.
   PubMed Web of Science ®Google Scholar
• Mulier S, Claes JP, Dierieck V, et al. (2012). Survival benefit of adding hyperthermic intraperitoneal chemotherapy (HIPEC) at the different time-points of treatment of ovarian cancer: review of evidence. Curr Pharm Des 18:3793–803. Review.
   PubMed Web of Science ®Google Scholar
• Spiliotis J, Halkia E, Lianos E, et al. (2015). Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study. Ann Surg Oncol 22:1570–75.
   PubMed Web of Science ®Google Scholar
• Tan GHC, Teo MC, Chen W, et al. (2013). Surgical management of colorectal peritoneal metastases: treatment and outcomes compared with hepatic metastases. J Gastrointest Cancer 44:170–76.
   PubMedGoogle Scholar
• Iversen LH, Rasmussen PC, Laurberg S. (2013). Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. Br J Surg 100:285–92.
   PubMed Web of Science ®Google Scholar
• Kusamura S, Baratti D, Hutanu I, et al. (2012). The importance of the learning curve and surveillance of surgical performance in peritoneal surface malignancy programs. Surg Oncol Clin N Am 21:559–76.
   PubMed Web of Science ®Google Scholar